Aarhus University Seal / Aarhus Universitets segl


2020.11.20 | News type

Join us for the ODIN Industry Pitches

In this video, ODIN's scientific facilitator Freja Bertelsen explains why you should attend the ODIN industry pitches by 11 national and international pharma- and biotech companies. Members of the ODIN network can register on our matchmaking platform and if you are not yet registered, you are more than welcome to contact Ditte Engholm at…

2020.11.09 | Events

ODIN Industry Pitches

Eleven companies participating in the ODIN initiative will pitch their research needs to the ODIN community to find potential collaborators.

Portrait of Georg Duenstl

2020.09.07 | Research news

The ODIN secreatariat received 19 funding applications in the first call round.

The applications have now been reviewed by our Project Review Committee and an international Peer Review Panel and the applications nominated for funding will soon be reviewed by our Steering Group.

2020.08.31 | Publication

The Head of ODIN actively engages in the research performed in open innovation in science

Recently, the Head of ODIN Maries Louise Conradsen co-authored the article “The Open Innovation in Science research field: a collaborative conceptualization approach” published in the journal Industry and Innovation. The article is, of course, open for everyone to read and you can read here: https://bit.ly/2DvonTH

2020.06.30 | Administrative conditions

ODIN project period extended to 30 April 2023

The Novo Nordisk Foundation has just approved the ODIN secretariat's request to extend the project period due to COVID-19 delays.

Foto: Aarhus Universitet.

2020.04.01 | Health and disease

Aarhus Universitet indgår åbent forskningssamarbejde med medicinalindustrien

I et nyt forskningssamarbejde mellem Aarhus Universitet og en række internationale lægemiddelproducenter, stilles data og resultater åbent og gratis til rådighed for omverdenen. Det er et attraktivt samarbejde for begge parter, mener både industrien og AU’s rektor.

2020.03.11 | Health and disease

Aarhus University and the pharmaceutical industry join forces on open innovation – a pathway to new medicines

Aarhus University and several international pharmaceutical companies are joining forces in the Open Discovery Innovation Network (ODIN), a ground-breaking open research collaboration for which the Novo Nordisk Foundation has awarded a grant of DKK 54.5 million. The data and results from the collaboration will be openly and freely available to…

Future events

Wed 02 Dec
09:15-10:00 | Online: Microsoft Teams
ODIN industry pitch - STipe Therapeutics ApS
Designing a new generation of cell-penetrating peptides
Wed 02 Dec
10:00-10:45 | Online: Microsoft Teams
ODIN Industry Pitch - Bioneer A/S
Bioneer’s approach to biomarker discovery and validation
Wed 02 Dec
10:45-11:30 | Online: Microsoft Teams
ODIN Industry Pitch - BioXpedia A/S
Standard and Customized Services supporting clinical research within Biomarker Discovery and Drug Target Validation
Thu 03 Dec
09:15-10:00 | Online: Microsoft Teams
ODIN Industry Pitch - Boehringer Ingelheim A/S
Open to innovation and collaboration: Opnme.com at Boehringer Ingelheim
Fri 04 Dec
09:05-10:00 | Online: Microsoft Teams
ODIN Industry Pitch - Omiics ApS
Biomarker discovery using RNA Next Generation sequencing (NGS)
Fri 04 Dec
10:00-10:45 | Online: Microsoft Teams
ODIN Industry Pitch - Novo Nordisk A/S
Discovering the Next Generation of Medicines for Metabolic Disease
Fri 04 Dec
10:45-11:30 | Online: Microsoft Teams
ODIN Industry Pitch - AstraZeneca AB
Research by AstraZeneca